Nirsevimab Frequently Asked Questions

• Sign in to bookmark this resource.

  Sign in

---

Access Resources

• Job AidEN

About

This webpage provides answers to frequently asked questions (FAQs) about nirsevimab, a monoclonal antibody used to prevent RSV in infants and young children. Topics include the following: ordering and supply; nirsevimab and palivizumab; administration, side effects/contraindications, and timing; recommendations; coding and payment; reporting; and talking to families.

---

Tags

Focus Area: Infectious Disease

Audiences: Nurses; Physicians; Public Health Professionals

Emergency Management Stage: Preparedness (Prevention / Protection)

Collection: Niresivemab Library

Keywords: Child Health Services; Immunization, Passive; Infant, Newborn; Respiratory Syncytial Viruses; Vaccines; Vaccines, Synthetic; Respiratory Syncytial Virus Vaccines

Institutions: American Academy of Pediatrics (AAP)

---

More like this

Nirsevimab (Beyfortus) Product & Ordering Information 2024 · American Academy of Pediatrics (AAP) COVID-19 Testing Guidance 2022 · American Academy of Pediatrics (AAP) Pediatric Anthrax Clinical Management 2014 · American Academy of Pediatrics (AAP)

---

The information provided on this website is for educational purposes only. It does not substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

---